Novel Pleural Fluid, Biopsy and Serum Biomarkers for the Investigation of Pleural Effusions
NCT03661801 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 313
Last updated 2020-11-05
Summary
The purpose of this study is to prospectively asses established biomarkers in the diagnosis and prognosis of patients and will include assessment of a number of biomarkers, genomics and proteomics.
Conditions
- Respiratory Disease
- Pleural Effusion
- Lung Cancer
Sponsors & Collaborators
-
Rocket Medical plc
collaborator OTHER -
University of Oxford
lead OTHER
Principal Investigators
-
Najib Rahman · University of Oxford
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-10-26
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural Effusion
NCT01256801 ·Status: COMPLETED
-
Monitoring the Changes of Tumor-related Biomarkers Before and After Pulmonary Nodule Biopsy.
NCT03397355 ·Status: UNKNOWN
-
Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer
NCT02855281 ·Status: COMPLETED
-
Plasma Proteomic Biomarkers for Early Diagnosis of Lung Cancer
NCT05742204 ·Status: ACTIVE_NOT_RECRUITING
-
Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers
NCT00185913 ·Status: COMPLETED
-
Organoid-guided Personalized Treatment of Pleural Effusion
NCT06959173 ·Status: RECRUITING
-
Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC
NCT05641870 ·Status: UNKNOWN
-
Multicenter Observational Study of Advanced Non-small Cell Lung Cancer With Malignant Pleural Effusion
NCT04263688 ·Status: UNKNOWN
-
Immune- and Microenvironment- Proteogenomics Profiling for Classifying Lung Cancer Patients
NCT04887545 ·Status: UNKNOWN
-
EB-OCT Biopsy Guidance of Lung Cancer
NCT06556680 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
BAL Fluid Biomarkers in Sarcoma
NCT06815666 ·Status: RECRUITING ·Phase: PHASE2
-
Biomarkers of Stage III Locally Advanced Unresectable Non-small-cell Lung Cancer
NCT04749407 ·Status: UNKNOWN
-
'Lung Health Check' Biomarker Study
NCT04957433 ·Status: UNKNOWN
-
A Study of Predictive and Prognostic Markers in Patients With Non-small Cell Lung Cancer
NCT00958555 ·Status: UNKNOWN
-
Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung Cancer
NCT04156360 ·Status: UNKNOWN
-
Oncodrivers in Malignant Pleural Effusions Associated With Non-small Cell Lung Cancer: A Prospective Study.
NCT04806412 ·Status: UNKNOWN ·Phase: NA
-
Assay Development for Cancer Biomarkers
NCT02874729 ·Status: UNKNOWN
-
Biomarkers for Diagnosis of Lung Cancer
NCT02050100 ·Status: COMPLETED
-
Longitudinal Follow up of Patients With Pleural Effusion
NCT04670562 ·Status: RECRUITING
-
Assessment of Novel Biomarkers in Participants Undergoing Targeted Lung Health Checks
NCT05902559 ·Status: RECRUITING
-
Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis
NCT04040244 ·Status: TERMINATED ·Phase: NA
-
Lung EpiCheck Biomarkers Development Study
NCT06245876 ·Status: RECRUITING
-
A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer
NCT04951154 ·Status: COMPLETED
-
A Study in Non-Small Cell Lung Cancer
NCT07174388 ·Status: RECRUITING
-
Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery
NCT05648370 ·Status: UNKNOWN